Melanoma Marker (MART-1 + Tyrosinase + gp100)

354 EUR

100ug

GEN438404

N/A

N/A

N/A

Antibodies

Monoclonal

MLANA (MART-1)

Melanoma Marker

Mnoclonal antibodies

Immunohistology (IH)

Mouse (Mus musculus)

DT101+ BC199 + T311 + HMB45

TYR (Tyrosinase); SILV (gp100)

MLANA; MLANA; MART1; MART-1; MART1; MART-1

IgG2b (M2-7C10 & M2-9E3) + IgG2a (T311) + IgG1 (HMB45)

Store the antibody at +4C. Temperature variations in the range of 1 to 7 degrees Celsius are tolerable. We recommend NOT to freeze the antibody. Antibody is stable for 24 months.

Human (Homo sapiens). Others not tested.; Due to limited knowledge and inability for testing each and every species, the reactivity of the antibody may extend to other species which are not listed hereby.

melanoma antigen recognized by T-cells 1; Melanoma antigen recognized by T-cells 1; melanoma antigen recognized by T-cells 1; antigen LB39-AA; antigen SK29-AA; protein Melan-A; melan-A; Antigen LB39-AA; Antigen SK29-AA; Protein Melan-A

This antibody cocktail recognizes three melanoma-specific proteins, which include MART-1, Tyrosinase and gp100. MART-1 is a newly identified melanocyte differentiation antigen recognized by autologous cytotoxic T lymphocytes. Tyrosinase is one of the targets for cytotoxic T-cell recognition in melanoma patients. Function of gp100 is not known but it is reported to be a useful marker for melanocytes and melanomas. This cocktail of three markers is designed for extremely sensitive labeling of formalin-fixed, paraffin-embedded melanomas and other tumors showing melanocytic differentiation.; Since it is not possible to test each and every species our knowledge on the corss reactivity of the antibodies is limited. This particular antibody might cross react with speacies outside of the listed ones.